BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34672255)

  • 1. Severe drug-induced immune hemolytic anemia due to cefmetazole: A case report.
    Fukuda M; Nabeta M; Oya S; Takasu O
    Int J Clin Pharmacol Ther; 2022 Jan; 60(1):52-56. PubMed ID: 34672255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug-induced immune hemolytic anemia caused by cefmetazole].
    Shioji N; Mizutani M; Okayama M; Katayama H; Ooya E; Sekine T; Masuya M
    Rinsho Ketsueki; 2018; 59(7):884-888. PubMed ID: 30078798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: Decreased hemoglobin and multiple organ failure caused by ceftizoxime-induced immune hemolytic anemia in a Chinese patient with malignant rectal cancer.
    Lou C; Liu M; Ma T; Yang L; Long D; Li J; Lei H; Xiang D; Wang X; Li L; Cai X
    Front Immunol; 2024; 15():1390082. PubMed ID: 38756782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature.
    Leicht HB; Weinig E; Mayer B; Viebahn J; Geier A; Rau M
    BMC Pharmacol Toxicol; 2018 Oct; 19(1):67. PubMed ID: 30359322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperacillin-tazobactam induced immune hemolytic anemia led to increased renal impairment and eventual death from multiple organ failure in a patient with hypertensive nephropathy: case report and literature review.
    Wu Y; Wu Y; Guo G; Zeng J; Liu Y; Wu Y
    BMC Nephrol; 2023 Jun; 24(1):173. PubMed ID: 37316798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe drug-induced immune hemolysis due to ceftriaxone.
    Dara RC; Sharma R; Bhardwaj H
    Asian J Transfus Sci; 2020; 14(2):187-191. PubMed ID: 33767548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alectinib-induced Immune Hemolytic Anemia in a Patient with Lung Adenocarcinoma.
    Okumoto J; Sakamoto S; Masuda T; Yamaguchi K; Horimasu Y; Miyamoto S; Nakashima T; Iwamoto H; Fukushima N; Fujitaka K; Hamada H; Hattori N
    Intern Med; 2021 Feb; 60(4):611-615. PubMed ID: 32999219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune hemolytic anemia with drug-induced antibodies to carboplatin and vincristine in a pediatric patient with an optic pathway glioma.
    Betensky M; Witmer C; Fisher MJ; Nance S; Weiss MJ; Sesok-Pizzini DA
    Transfusion; 2014 Nov; 54(11):2901-5. PubMed ID: 24860959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bosentan-induced immune hemolytic anemia in 17 years old man. A case report.
    Afra F; Mehri M; Namazi S
    Daru; 2021 Jun; 29(1):211-215. PubMed ID: 33486694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first reported case of concurrent trimethoprim-sulfamethoxazole-induced immune hemolytic anemia and thrombocytopenia.
    Linnik YA; Tsui EW; Martin IW; Szczepiorkowski ZM; Denomme GA; Gottschall JL; Hill JM; Dunbar NM
    Transfusion; 2017 Dec; 57(12):2937-2941. PubMed ID: 28905389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced immune hemolytic anemia associated with anti-vancomycin complicated by a paraben antibody.
    Gniadek TJ; Arndt PA; Leger RM; Zydowicz D; Cheng EY; Zantek ND
    Transfusion; 2018 Jan; 58(1):181-188. PubMed ID: 28990203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune hemolytic anemia caused by drugs.
    Garratty G
    Expert Opin Drug Saf; 2012 Jul; 11(4):635-42. PubMed ID: 22502777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone-Induced Hemolytic Anemia: A Rare Case Report.
    Kumar S; Bansal R; Bansal P; Dhamija RK; Neurology D
    Perm J; 2020; 24():. PubMed ID: 31905339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of immune hemolytic anemia induced by ceftizoxime and cefobactam (sulbactam/cefoperazone).
    Baek EJ; Lee S; Kim S; Choi HK; Kim HO
    Korean J Lab Med; 2009 Dec; 29(6):578-84. PubMed ID: 20046091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced immune hemolytic anemia.
    Garratty G
    Hematology Am Soc Hematol Educ Program; 2009; ():73-9. PubMed ID: 20008184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune hemolytic anemia associated with trimethoprim-sulfamethoxazole use.
    Frieder J; Mouabbi JA; Zein R; Hadid T
    Am J Health Syst Pharm; 2017 Jun; 74(12):894-897. PubMed ID: 28596226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced immune hemolytic anemia: the last 30 years of changes.
    Arndt PA
    Immunohematology; 2014; 30(2):44-54. PubMed ID: 25247622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefotetan-Induced Hemolytic Anemia: Case Series and Review.
    Lim K; Tran H; Hirai-Yang A; Vakil N; Marks G; Klapper E
    J Pharm Pract; 2019 Dec; 32(6):679-682. PubMed ID: 30189781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced hemolysis: cefotetan-dependent hemolytic anemia mimicking an acute intravascular immune transfusion reaction.
    Stroncek D; Procter JL; Johnson J
    Am J Hematol; 2000 May; 64(1):67-70. PubMed ID: 10815791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia--a new paradigm.
    Johnson ST; Fueger JT; Gottschall JL
    Transfusion; 2007 Apr; 47(4):697-702. PubMed ID: 17381629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.